Prospective, randomized, open-label, clinical trial comparing the different Sufonyl Urea(SU) combination with DPP4 inhibitor.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 09 Jan 2015
At a glance
- Drugs Glibenclamide (Primary) ; Gliclazide (Primary) ; Glimepiride (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 16 Jan 2010 New trial record